Corcept Therapeutics Incorporated (CORT) Stock Price & Financial Analysis
Corcept Therapeutics Incorporated Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Corcept Therapeutics Incorporated
What is the current stock price for CORT?
As of the latest trading session, CORT stock trades at $59.06. The 52-week range is $28.66–$91.00, with a day range of $57.10–$59.55.
What is the P/E ratio for CORT?
Corcept Therapeutics Incorporated's trailing P/E ratio is 130.8, meaning investors pay $130.8 for every $1 of annual earnings. The forward P/E is 294.8, reflecting analyst expectations for future earnings.
Does CORT pay dividends?
Corcept Therapeutics Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CORT?
Based on 3 analysts, the consensus for CORT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CORT?
Corcept Therapeutics Incorporated's market capitalization is $6.17B, classifying it as a mid-cap company..